NYSE:WAT - Waters Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$193.87 +0.88 (+0.46 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$192.99
Today's Range$192.28 - $194.58
52-Week Range$171.32 - $220.20
Volume567,900 shs
Average Volume565,994 shs
Market Capitalization$15.12 billion
P/E Ratio25.88
Dividend YieldN/A
Beta0.94
Waters logoWaters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. The company also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. In addition, the company offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for use in various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNYSE:WAT
CUSIP94184810
Phone508-478-2000

Debt

Debt-to-Equity Ratio0.59
Current Ratio6.44
Quick Ratio5.87

Price-To-Earnings

Trailing P/E Ratio25.88
Forward P/E Ratio23.61
P/E Growth2.25

Sales & Book Value

Annual Sales$2.31 billion
Price / Sales6.58
Cash Flow$8.9672 per share
Price / Cash21.62
Book Value$28.09 per share
Price / Book6.90

Profitability

EPS (Most Recent Fiscal Year)$7.49
Net Income$20.31 million
Net Margins1.14%
Return on Equity25.80%
Return on Assets12.27%

Miscellaneous

Employees7,000
Outstanding Shares78,340,000

Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters declared that its Board of Directors has authorized a share buyback program on Tuesday, April 24th 2018, which permits the company to buyback $3,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 18.2% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its shares are undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) issued its quarterly earnings data on Tuesday, April, 24th. The medical instruments supplier reported $1.59 EPS for the quarter, beating the consensus estimate of $1.55 by $0.04. The medical instruments supplier earned $530.70 million during the quarter, compared to analysts' expectations of $534.17 million. Waters had a return on equity of 25.80% and a net margin of 1.14%. The company's quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.46 earnings per share. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for Waters.

What guidance has Waters issued on next quarter's earnings?

Waters issued an update on its FY18 earnings guidance on Tuesday, April, 24th. The company provided earnings per share guidance of $8.10-8.30 for the period, compared to the Thomson Reuters consensus estimate of $8.19.

What price target have analysts set for WAT?

17 equities research analysts have issued twelve-month price objectives for Waters' shares. Their predictions range from $180.00 to $230.00. On average, they expect Waters' share price to reach $206.5333 in the next twelve months. View Analyst Ratings for Waters.

Who are some of Waters' key competitors?

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 51)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 54)
  • Dr. Michael C. Harrington, Sr. VP of Global Markets (Age 57)
  • Mr. Ian S. King, Sr. VP of Global Products (Age 61)
  • Mr. Eugene G. Cassis, Sr. Advisor (Age 61)

Has Waters been receiving favorable news coverage?

Media stories about WAT stock have trended somewhat positive this week, Accern reports. Accern identifies negative and positive media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Waters earned a news sentiment score of 0.11 on Accern's scale. They also gave news coverage about the medical instruments supplier an impact score of 48.19 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Waters' major shareholders?

Waters' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.20%), Massachusetts Financial Services Co. MA (6.33%), Baillie Gifford & Co. (3.29%), Veritas Asset Management LLP (2.50%), Northern Trust Corp (1.38%) and Franklin Resources Inc. (1.14%). Company insiders that own Waters stock include Arthur G Caputo, Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

Which major investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Veritas Asset Management LLP, Baillie Gifford & Co., Schroder Investment Management Group, Boston Partners, Millennium Management LLC, Swiss National Bank and American Century Companies Inc.. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Insider Buying and Selling for Waters.

Which major investors are buying Waters stock?

WAT stock was purchased by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Citigroup Inc., Bamco Inc. NY, Summit Trail Advisors LLC, JPMorgan Chase & Co., Royal Bank of Canada, Ontario Teachers Pension Plan Board and Champlain Investment Partners LLC. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $193.87.

How big of a company is Waters?

Waters has a market capitalization of $15.12 billion and generates $2.31 billion in revenue each year. The medical instruments supplier earns $20.31 million in net income (profit) each year or $7.49 on an earnings per share basis. Waters employs 7,000 workers across the globe.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  297 (Vote Outperform)
Underperform Votes:  410 (Vote Underperform)
Total Votes:  707
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.